This strategy, which eliminates drugresistance
markers in live vaccines, has been successfully used
in case of other live vaccines. Based on so far published data,
using GEM vs live LAB strains for human immunization will
be determined by the required type of immune response as
well as by the most efficient route of immunization, and it
has to be verified in clinical trials